|
Pamela Scott Adams Mary Kay Dolejsi Susan Hardin Doug McMinimy Paul Morrison John Rush |
W. Alton Jones Cell Science
Center, Lake Placid, NY Fred Hutchinson Cancer Research Center, Seattle, WA University of Houston, Houston, TX The Jackson Laboratory, Bar Harbor, ME Dana-Farber Cancer Institute, Boston, MA Howard Hughes Medical Institute, Harvard Medical School Boston, MA |
THE "LUNATIC" SEQUENCE: The Lunatic fringe (3) Genbank accession No. is U91849.
SUMMARY OF COMMON PARAMETERS:
PARTICIPATION : The number, type and WTR (well to read) of sequencers which were used in this study .
RANKINGS: All sequences submitted by the participants were trimmed of approximately 50 bases at the 5' end to to eliminate any variables in this area, since we were only interested in laboratories' ability to sequence through GC rich areas. The sequences were then compared with the known sequence and the cumulative number of errors was determined for each sequence. Miscalls, insertions, deletions and N's were considered errors. No entry in an error column indicates that there were too many errors to count. The sequences were then sorted according to the number of errors in the 0-600 column, 0-400 column and lastly 0-200 column for all the types of machines which have a greater than 24 cm WTR. For the ABI 373A which has a 24 cm WTR ( well to read), the sequences were sorted by the 0-400 column and then the 0-200 column. The Code column shows the participants 4 digit identification number preceded by N = not edited or E = edited. The letters following the code are D = 5% DMSO only, AT = Altered Thermocycling conditions were used, DAT = DMSO plus AT. No letter indicates that standard manufacturer's conditions were used. One participant used AC = altered chemistry, which was reported as a buffer modification. 0.5 after a code indicates that "half" reactions were used. The type of machine and the WTR are indicated for each. In cases where there are more than one sequence with identical scores, the ranking order is random. TOP 10: The sequences were sorted by code number (lab) and then by the 0-600 error column. The best sequence from each lab was then selected. These 10 best sequences were then further analyzed out to 1000 bases and ranked according to the longest read with no errors. The first number in the 0-800 column shows the base at which the first error occurred. The second number shows the number of cumulative errors out to 800 bases. A third number, followed by a * indicates that no further data was collected beyond that point. The parameters provided by the labs are included. EFFECT OF REACTION CONDITIONS ON UNEDITED SEQUENCE ACCURACY : Analysis of ALL sequences, regardless of gel length (WTR), showing the effects of adding DMSO, using altered thermocycling conditions or a combination of both. The high number of errors in the 0-600 range may reflect the inclusion of the data from the 373A machines (24 cm WTR) which probably do not generate accurate sequence in the 400-600 base range. EFFECT OF REACTION CONDITIONS ON EDITED SEQUENCE ACCUARACY : Analysis of ALL sequences, regardless of gel length (WTR), showing the effects of adding DMSO, using altered thermocycling conditions or a combination of both. The high number of errors in the 0-600 range may reflect the inclusion of the data from the 373A machines (24 cm WTR) which probably do not generate accurate sequence in the 400-600 base range. EDITING SIGNIFICANTLY IMPROVES SEQUENCE ACCURACY : Analysis of ALL sequences, regardless of condition or gel length (WTR), showing the effects of editing. The high number of errors in the 0-600 range may reflect the inclusion of the data from the 373A machines (24 cm WTR) which probably do not generate accurate sequence in the 400-600 base range.SAMPLE CHROMATOGRAM: An example of an unedited sequence showing the GC rich nature of this template and the benefits to be gained by manual editing. This sample was run under standard conditions using dye terminator chemistry on a 373S using a 48 cm (WTR) gel.
Send comments or suggestions to: Scottie Adams
Back to the Association of Biomolecular Resource Facilities (ABRF) Homepage
©1997 ABRF